You just read:

Depomed Acquires CAMBIA® (Diclofenac Potassium for Oral Solution) Migraine Medicine from Nautilus Neurosciences for $48.7 Million

News provided by

Depomed, Inc.

Dec 17, 2013, 04:05 ET